Bradley Pharmaceuticals
Executive Summary
Company acquires Berlex Labs' prescription Deconamine cold/decongestant products line for $16.5 mil. Under the agreement, Schering AG's Berlex unit will receives $4 mil. at closing Nov. 19; $500,000 on Dec. 19; and $2 mil. Feb. 18, 1994, with the remaining $10 mil. paid in annual installments beginning Nov. 19, 1994. A $2 mil. contingency payment would be spread over two years starting Jan. 1, 1996. Estimated U.S. sales of Deconamine are about $10 mil.